Hepatitis B Virus Profile among Blood Donors in the Capital Territory Abuja, Nigeria
Journal: International Journal of Science and Research (IJSR) (Vol.5, No. 7)Publication Date: 2016-07-05
Authors : Agbesor. N. Innocent; Amala Smart E.; Zaccheaus. A. Jeremiah;
Page : 1668-1672
Keywords : Hepatitis B; Blood donors; Serological markers Hepatitis B; Blood donors; Serological markers Hepatitis B; Blood donors; Serological markers Hepatitis B; BloodDonors; Serological markers;
Abstract
This study was carried out to detect the prevalence of five markers of Hepatitis B virus (HBV) among prospective blood donors between the ages 18-65 years from Asokoro General Hospital Abuja, Nigeria. They were screened for Hepatitis B virus using a rapid stepwise HBV -5 panel immunoassay of Combo Cassette Manufactured by Lusys Laboratories Inc U. S. A. The overall prevalence rate of the five respective markers were HBsAg 18 (17.5), HBeAg 2 (1.9), HBsAb 18 (17.5), HBeAb 25 (24.5), and HBc 63 (61.2). Donors aged (30-40) years had the highest prevalence rate of hepatitis B virus infection compared to age groups 21-30 years and 41 years and above. Statistically, there was significant relationship between the prevalence rate of HBsAg and frequency of donation at p (0.05). Most of the samples that tested negative for HBsAg were found to be positive for other markers especially anti-HBc IgG and IgM). While anti- HBc IgG is useful for the detection of chronic HBV infection, anti-HBc IgM is useful in detecting recent infection of HBV. Thus, this study has showed that screening for HBsAg alone may not be sufficient for the diagnosis of hepatitis B virus infection.
Other Latest Articles
- An Advanced Survey on Hierarchical Routing Protocols in WSN
- Synthesis and Photoluminescence Properties of Eu3+ Doped Strontium Cerium Sulfide Phosphor
- Prediction of Violent Behaviour in Psychiatryc Emergency Room
- Physical Infrastructure Planning and Management for Sustainable Development in Ramtek Town
- Qualitative and Quantitative Analysis of Bioactive Constituents Present in Seed Extracts of Phoenix sylvestris
Last modified: 2021-07-01 14:40:32